$PFE Pfizer and BioNTech $BNTX Granted FDA Fast Track Designation for Two Investigational mRNA-based Vaccine Candidates Against SARS-CoV-2; Expects to start a Phase 2b/3 trial as soon as later this month
(More at https://t.co/5e9rXlgCqO)